Influence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric flora

Pediatric Nephrology

Volumn 21, Issue 6, 2006, Pages 807-810

  Akil, Ipek ^a,b   Yilmaz, Ozge ^a   Kurutepe, Semra ^a   Degerli, Kenan ^a   Kavukcu, Salih ^b  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Escherichia coli; Prevention; Saccharomyces boulardii; Urinary tract infection

Indexed keywords

PROBIOTIC AGENT;

ADOLESCENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIOLOGY; BACTERIUM COLONY; CHILD; CLINICAL ARTICLE; COLON; COLONY FORMING UNIT; DRUG EFFICACY; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; HUMAN; INTESTINE FLORA; INTESTINE INFECTION; MALE; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES BOULARDII; STATISTICAL ANALYSIS; URINARY TRACT INFECTION;

ADMINISTRATION, ORAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; COLON; COLONY COUNT, MICROBIAL; DIETARY SUPPLEMENTS; ESCHERICHIA COLI; FECES; FEMALE; HUMANS; MALE; PROBIOTICS; SACCHAROMYCES; URINARY TRACT INFECTIONS;

EID: 33646674416     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0088-4     Document Type: Article

References (18)

1. Stull TL, LiPuma JJ (1991) Epidemiology and natural history of urinary tract infections in children. Med Clin North Am 75:287-297
2. Dunne C, O'Mahony L, Murphy L, Thornton G, Morrissey D, O'Halloran S, Feeney M, Flynn S, Fitzgerald G, Daly C, Kiely B, O'Sullivan GC, Shanahan F, Collins JK (2001) In vitro selection criteria for probiotic bacteria of human origin: Correlation with in vivo findings. Am J Clin Nutr 73:386S-392S
3. Elmer GW, Surawicz CM, McFarland LV (1996) Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 275:870-876
4. McFarland LV, Elmer GW (1995) Biotherapeutic agents: Past, present and future. Microecology Ther 23:46-73
5. McFarland LV, Bernasconi P (1993) Saccharomyces boulardii: A review of an innovative biotherapeutic agent. Microb Ecol Health Dis 6:157-171
6. Czerucka D, Dahan S, Mograbi B, Rossi B, Rampal P (2000) Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect Immun 68:5998-6004
7. Kontiokari T, Nuutinen M, Uhari M (2004) Dietary factors affecting susceptibility to urinary tract infection. Pediatr Nephrol 19:378-383
8. Reid G (2001) Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 73(Suppl):437S-443S
9. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF (2002) Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 82:103-108
10. Mombelli B, Gismondo MR (2000) The use of probiotics in medical practice. Int J Antimicrob Agents 16:531-536
11. Dahan S, Dalmasso G, Imbert V, Peyron JF, Rampal P, Czerucka D (2003) Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli -induced signaling pathways in T84 cells. Infect Immun 71:766-773
12. Rodrigues AC, Cara DC, Fretez SH, Cunha FQ, Vieira EC, Nicoli JR, Vieira LQ (2000) Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol 89:404-414
13. Reid G, Burton J (2002) Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect 4:319-324
14. Howell AB, Vorsa N, Der Marderosian A, Foo LY (1998) Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. N Engl J Med 339:1085-1086
15. Burkhardt O, Kohnlein T, Pletz M, Welte T (2005) Saccharomyces boulardii induced sepsis: Successful therapy with voriconazole after treatment failure with fluconazole. Scand J Infect Dis 37:69-71
16. Schlager TA, Hendley JO, Bell AL, Whittam TS (2002) Clonal diversity of Escherichia coli colonizing stools and urinary tracts of young children. Infect Immun 70:1225-1229
17. Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M (2001) Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 322:1571-1573
18. Reid G, Bruce AW, Taylor M (1992) Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther 14:11-16